Developer docs
API playgroundTry for free, no card

Search company profiles

TEKTON RESEARCH

Full company profile

uuid0004txk

Namestring
TEKTON RESEARCH
Legal namestring
Tekton Research
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Tekton Research is a physician-led, multi-site clinical research organization founded in 2006 and headquartered in Austin, Texas. The company operates more than 25 research sites across nine US states (Texas, Colorado, Oklahoma, Kansas, New Jersey, Georgia, Virginia, Ohio, and Missouri), executing Phase 1-4 clinical trials in neuroscience and psychiatry, cardiometabolic and endocrine, general medicine, infectious disease and vaccines, and pediatrics. Its core product is a distributed site network that delivers patient enrollment, data collection, rater-calibrated CNS assessments, and regulatory-compliant site operations on behalf of study sponsors. Tekton monetizes through professional-services fees billed per patient enrolled, per visit completed, and per protocol complexity to pharmaceutical sponsors, contract research organizations (CROs), and biotech companies; per-patient participant compensation is structured separately and is not a revenue stream for the company.

The company's go-to-market is sales-led, with a business development team engaging enterprise sponsors and CROs directly, supported by participation in industry conferences (EASD, SCRS Global Site Solutions Summit, CNS Summit, Obesity Week, AES), content marketing, and partnerships with SCRS and AMRC. Tekton holds alliance relationships with named CROs including Parexel (Alliance Site) and Worldwide Clinical Trials, and has a strategic partnership with Summit Clinical Research for MASH/NASH trials. On the technology side, Tekton deployed Todata Analytics' SiteGrades platform and Tod AI layer as an enterprise business intelligence layer across its network in November 2025 to support data analysis and capacity planning. Operational performance metrics include sub-24-hour site activation, 95% participant retention, and a 20.3-day average contract turnaround against an industry benchmark of 30+ days.

Since September 2023, Tekton has operated as a majority-owned portfolio company of Havencrest Capital Management. Under that ownership, the company has pursued an active growth agenda: multi-state site expansion (Ohio and New Jersey in November 2025; San Antonio multi-specialty hub in April 2026), senior leadership additions across commercial and therapeutic-area functions, and entry into new therapeutic verticals such as MASH/NASH. The company employs between 51 and 100 staff, with its distributed site footprint forming the bulk of operational capacity.

Short descriptiontext

Tekton Research is a physician-led, multi-site clinical research organization operating 25+ sites across 9 US states, conducting Phase 1-4 clinical trials in neuroscience, cardiometabolic, general medicine, infectious disease, and pediatrics for pharmaceutical sponsors, CROs, and biotech companies. Founded in 2006; majority-owned by Havencrest Capital Management since 2023.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices22 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial site network, multi-site clinical research, clinical trial services, clinical research organization, physician-led research sites
Industry2 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Clinical Research Site Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services
TypeProfessional Services
Description

Revenue is generated through fees charged to pharmaceutical sponsors, CROs, and biotech companies for conducting clinical trials at Tekton's network of physician-led research sites. Fees are typically structured per patient enrolled, per visit completed, and according to protocol complexity. The company operates as a site network providing patient enrollment, data collection, regulatory compliance, and site operations services to study sponsors.

tektonresearch.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Study-specific participant compensation
ModelOtherBilling cadencePay-as-you-go
Notes

Payment reflects number of visits, procedures at each visit, between-visit requirements (tracking symptoms in apps, questionnaires), study duration, study phase, and setting. Shorter studies with fewer visits offer smaller payments; longer studies with intensive monitoring offer higher compensation. Most trials pay as participants complete visits rather than upfront.

tektonresearch.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Tekton Research operates a network of 25+ physician-led clinical research sites across 9 U.S. states, conducting Phase 1–4 clinical trials for pharmaceutical sponsors, CROs, and biotech companies. The organization provides patient enrollment, site operations, data collection, regulatory compliance, and rater-calibrated assessments across therapeutic areas including neurology, psychiatry, cardiometabolic disease, infectious disease, general medicine, and pediatrics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% participant retention rate
+3 more records
Product and service6 records
1Neurology & Psychiatry Clinical Trials
CategoryTherapeutic Area Service
Description

Phase 1-4 CNS clinical trial services covering depression, pain, Alzheimer's disease, migraine, addiction, and other neurologic and psychiatric conditions, with experienced investigators and calibrated rater training for rater-dependent studies.

2Cardiometabolic & Endocrine Clinical Trials
CategoryTherapeutic Area Service
Description

Clinical trial services for Type 1 and Type 2 diabetes, obesity, MASH/MASLD, thyroid conditions, and related metabolic disorders, staffed by board-certified endocrinologists and obesity medicine specialists.

3Vaccines & Infectious Disease Trials
CategoryTherapeutic Area Service
Description

Vaccine and infectious disease trial services across 20+ sites covering flu, RSV, COVID-19, hMPV, herpes, combination vaccines, and diagnostic studies.

4General Medicine Clinical Trials
CategoryTherapeutic Area Service
Description

General medicine clinical trial services covering allergy, COPD, asthma, atopic dermatitis, and other common chronic conditions, leveraging large, well-profiled patient populations.

5Pediatric Clinical Trials
CategoryTherapeutic Area Service
Description

Pediatric clinical trial services across dedicated pediatric sites supporting studies in pediatric populations alongside adult and maternal populations.

6San Antonio Multi-Specialty Clinical Research Hub
CategorySite Facility
Description

Multi-specialty clinical research hub in San Antonio, Texas, serving pharmaceutical sponsors and CROs running cardiometabolic and endocrine trials with concentrated physician-led capacity.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2025-11-05
Description

Tekton selected Todata's SiteGrades platform and Tod AI layer as enterprise business intelligence solutions to support expansion to 25+ research sites. The analytics tools aim to streamline data analysis and capacity planning across the network, particularly in neurology, cardiometabolic, and vaccine research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-01
Description

Strategic partnership to expand into MASH/NASH clinical trials. The collaboration launched at Tekton's Yukon, Oklahoma site under PI Dr. Robert Lockwood. Summit provides specialized support including investigator onboarding, protocol training, regulatory readiness, and ongoing mentorship. Within 5 days of activation, the first patient was screened.

Strategic tierPartnerTypeStrategic or Co-development Partner
Description

Partner logo displayed on Tekton Research website indicating collaborative working relationship for clinical trial execution.

Strategic tierPartnerTypeStrategic or Co-development Partner
Description

Parexel Alliance Site partnership. Tekton is recognized as a Parexel Alliance Site partner for clinical trial execution.

Strategic tierPartnerTypeTechnology or Integration
Description

Partner logo displayed on website indicating collaborative relationship for site operations and patient recruitment technology.

6SCRS - Society for Clinical Research Sites
Strategic tierPartnerTypeGTM or Marketing Partner
Description

Partnership with SCRS for industry engagement, thought leadership, and representation in the clinical research site community. Tekton participates in SCRS events and podcast series.

tektonresearch.com
Strategic tierPartnerTypeTechnology or Integration
Description

Partner logo displayed indicating use of Advarra Clinical Conductor for clinical trial management and regulatory compliance.

Strategic tierPartnerTypeTechnology or Integration
Description

Partner logo displayed indicating use of CITI-Program for research ethics training and compliance.

9AMRC - Association of Multisite Clinical Research Corporations
Strategic tierPartnerTypeGTM or Marketing Partner
Description

Member of AMRC, the Association of Multisite Clinical Research Corporations, representing the interests of multi-site research organizations.

tektonresearch.com
Strategic tierPartnerTypeTechnology or Integration
Description

Partner logo displayed indicating use of Complion for document management and compliance solutions.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Velocity Clinical Research is a PE-backed (GHO Capital) multi-site clinical research organization operating a comparable U.S. site network. It is the most structurally similar competitor, with parallel physician-led model, therapeutic breadth, and roll-up growth strategy.

TypeBroad incumbent
Description

Medpace is a mid-size full-service CRO with a meaningful dedicated clinical trial site network across the U.S. and Europe. It competes for sponsor and CRO site-selection decisions, but operates a much broader service portfolio than Tekton's site-only model.

TypeDirect peer
Description

Flourish Research is a multi-site clinical research organization operating integrated research sites across multiple U.S. states with a similar physician-led model. Comparable in therapeutic breadth and operational positioning to Tekton.

TypeDirect peer
Description

Summit Clinical Research is a specialty site network focused on MASH/NASH and metabolic disease trials. Although Tekton's strategic partner, Summit operates its own competing site network targeting the same cardiometabolic sponsors.

TypeBroad incumbent
Description

Worldwide Clinical Trials is a mid-size global CRO with significant CNS and cardiometabolic focus. While listed as a Tekton partner, it also operates its own investigator site relationships and competes for the same sponsor study awards.

TypeBroad incumbent
Description

ICON plc is one of the largest global CROs with extensive site network capabilities through its acquired site alliances and embedded site services. Competes for large sponsor programs where Tekton is often a sub-site partner.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with a vast global site network and full-service capabilities. Represents the upper bound of the competitive landscape and the preferred-provider alternative for large pharma sponsors.

TypeBroad incumbent
Description

Labcorp Drug Development (formerly Covance) is a top-tier global CRO offering both central laboratory services and clinical trial site network capabilities. Competes in the same sponsor contracts Tekton targets, particularly for integrated lab + site programs.

TypeBroad incumbent
Description

Parexel is a global CRO with deep CNS and oncology expertise and an established Alliance Site network that includes Tekton. Competes with Tekton for sponsor site-selection decisions but also routes selected studies through Tekton via the Alliance program.

TypeBroad incumbent
Description

Syneos Health is a global biopharmaceutical solutions provider with combined CRO and commercial capabilities, including site network services. Competes in sponsor preferred-provider decisions and has overlap with Tekton's therapeutic focus areas.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TEKTON RESEARCH

Clinical Research Site Servicestektonresearch.com

Tekton Research is a physician-led, multi-site clinical research organization operating 25+ sites across 9 US states, conducting Phase 1-4 clinical trials in neuroscience, cardiometabolic, general medicine, infectious disease, and pediatrics for pharmaceutical sponsors, CROs, and biotech companies. Founded in 2006; majority-owned by Havencrest Capital Management since 2023.

What TEKTON RESEARCH does

Tekton Research is a physician-led, multi-site clinical research organization founded in 2006 and headquartered in Austin, Texas. The company operates more than 25 research sites across nine US states (Texas, Colorado, Oklahoma, Kansas, New Jersey, Georgia, Virginia, Ohio, and Missouri), executing Phase 1-4 clinical trials in neuroscience and psychiatry, cardiometabolic and endocrine, general medicine, infectious disease and vaccines, and pediatrics. Its core product is a distributed site network that delivers patient enrollment, data collection, rater-calibrated CNS assessments, and regulatory-compliant site operations on behalf of study sponsors. Tekton monetizes through professional-services fees billed per patient enrolled, per visit completed, and per protocol complexity to pharmaceutical sponsors, contract research organizations (CROs), and biotech companies; per-patient participant compensation is structured separately and is not a revenue stream for the company.

The company's go-to-market is sales-led, with a business development team engaging enterprise sponsors and CROs directly, supported by participation in industry conferences (EASD, SCRS Global Site Solutions Summit, CNS Summit, Obesity Week, AES), content marketing, and partnerships with SCRS and AMRC. Tekton holds alliance relationships with named CROs including Parexel (Alliance Site) and Worldwide Clinical Trials, and has a strategic partnership with Summit Clinical Research for MASH/NASH trials. On the technology side, Tekton deployed Todata Analytics' SiteGrades platform and Tod AI layer as an enterprise business intelligence layer across its network in November 2025 to support data analysis and capacity planning. Operational performance metrics include sub-24-hour site activation, 95% participant retention, and a 20.3-day average contract turnaround against an industry benchmark of 30+ days.

Since September 2023, Tekton has operated as a majority-owned portfolio company of Havencrest Capital Management. Under that ownership, the company has pursued an active growth agenda: multi-state site expansion (Ohio and New Jersey in November 2025; San Antonio multi-specialty hub in April 2026), senior leadership additions across commercial and therapeutic-area functions, and entry into new therapeutic verticals such as MASH/NASH. The company employs between 51 and 100 staff, with its distributed site footprint forming the bulk of operational capacity.

TEKTON RESEARCH firmographics

Firmographics
Name
TEKTON RESEARCH
Legal name
Tekton Research
Website
https://tektonresearch.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
101–250 employees
Short description
Tekton Research is a physician-led, multi-site clinical research organization operating 25+ sites across 9 US states, conducting Phase 1-4 clinical trials in neuroscience, cardiometabolic, general medicine, infectious disease, and pediatrics for pharmaceutical sponsors, CROs, and biotech companies. Founded in 2006; majority-owned by Havencrest Capital Management since 2023.
Ownership category
akta.pro rank

TEKTON RESEARCH industry classification

Industry
Product category
Clinical Research Site Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Clinical trial site network
  • Multi-site clinical research
  • Clinical trial services
  • Clinical research organization
  • Physician-led research sites

Where TEKTON RESEARCH is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices22 records

Markets served

TEKTON RESEARCH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Services: Revenue is generated through fees charged to pharmaceutical sponsors, CROs, and biotech companies for conducting clinical trials at Tekton's network of physician-led research sites. Fees are typically structured per patient enrolled, per visit completed, and according to protocol complexity. The company operates as a site network providing patient enrollment, data collection, regulatory compliance, and site operations services to study sponsors.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStudy-specific participant compensation

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

TEKTON RESEARCH product offering

Product offering

Core offering

Tekton Research operates a network of 25+ physician-led clinical research sites across 9 U.S. states, conducting Phase 1–4 clinical trials for pharmaceutical sponsors, CROs, and biotech companies. The organization provides patient enrollment, site operations, data collection, regulatory compliance, and rater-calibrated assessments across therapeutic areas including neurology, psychiatry, cardiometabolic disease, infectious disease, general medicine, and pediatrics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Neurology & Psychiatry Clinical Trials Phase 1-4 CNS clinical trial services covering depression, pain, Alzheimer's disease, migraine, addiction, and other neurologic and psychiatric conditions, with experienced investigators and calibrated rater training for rater-dependent studies.
  • Cardiometabolic & Endocrine Clinical Trials Clinical trial services for Type 1 and Type 2 diabetes, obesity, MASH/MASLD, thyroid conditions, and related metabolic disorders, staffed by board-certified endocrinologists and obesity medicine specialists.
  • Vaccines & Infectious Disease Trials Vaccine and infectious disease trial services across 20+ sites covering flu, RSV, COVID-19, hMPV, herpes, combination vaccines, and diagnostic studies.
  • General Medicine Clinical Trials General medicine clinical trial services covering allergy, COPD, asthma, atopic dermatitis, and other common chronic conditions, leveraging large, well-profiled patient populations.
  • Pediatric Clinical Trials Pediatric clinical trial services across dedicated pediatric sites supporting studies in pediatric populations alongside adult and maternal populations.
  • San Antonio Multi-Specialty Clinical Research Hub Multi-specialty clinical research hub in San Antonio, Texas, serving pharmaceutical sponsors and CROs running cardiometabolic and endocrine trials with concentrated physician-led capacity.

Quantifiable outcome

  • 95% participant retention rate
  • +3 more outcomes

Companies that use TEKTON RESEARCH

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles2 records

TEKTON RESEARCH technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

TEKTON RESEARCH partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered strategic, core and partner.

  • Todata AnalyticsstrategicTechnology or Integration · 5 November 2025Tekton selected Todata's SiteGrades platform and Tod AI layer as enterprise business intelligence solutions to support expansion to 25+ research sites. The analytics tools aim to streamline data analysis and capacity planning across the network, particularly in neurology, cardiometabolic, and vaccine research.
  • Summit Clinical ResearchcoreStrategic or Co-development Partner · 1 July 2025Strategic partnership to expand into MASH/NASH clinical trials. The collaboration launched at Tekton's Yukon, Oklahoma site under PI Dr. Robert Lockwood. Summit provides specialized support including investigator onboarding, protocol training, regulatory readiness, and ongoing mentorship. Within 5 days of activation, the first patient was screened.
  • Worldwide Clinical TrialspartnerStrategic or Co-development PartnerPartner logo displayed on Tekton Research website indicating collaborative working relationship for clinical trial execution.
  • ParexelpartnerStrategic or Co-development PartnerParexel Alliance Site partnership. Tekton is recognized as a Parexel Alliance Site partner for clinical trial execution.
  • BEKHealthpartnerTechnology or IntegrationPartner logo displayed on website indicating collaborative relationship for site operations and patient recruitment technology.
  • SCRS - Society for Clinical Research SitespartnerGTM or Marketing PartnerPartnership with SCRS for industry engagement, thought leadership, and representation in the clinical research site community. Tekton participates in SCRS events and podcast series.
  • Advarra Clinical ConductorpartnerTechnology or IntegrationPartner logo displayed indicating use of Advarra Clinical Conductor for clinical trial management and regulatory compliance.
  • CITI-ProgrampartnerTechnology or IntegrationPartner logo displayed indicating use of CITI-Program for research ethics training and compliance.
  • AMRC - Association of Multisite Clinical Research CorporationspartnerGTM or Marketing PartnerMember of AMRC, the Association of Multisite Clinical Research Corporations, representing the interests of multi-site research organizations.
  • ComplionpartnerTechnology or IntegrationPartner logo displayed indicating use of Complion for document management and compliance solutions.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

TEKTON RESEARCH competitors and assessment

Company assessment

Direct peers

  • Velocity Clinical Research: Velocity Clinical Research is a PE-backed (GHO Capital) multi-site clinical research organization operating a comparable U.S. site network. It is the most structurally similar competitor, with parallel physician-led model, therapeutic breadth, and roll-up growth strategy.
  • Flourish Research: Flourish Research is a multi-site clinical research organization operating integrated research sites across multiple U.S. states with a similar physician-led model. Comparable in therapeutic breadth and operational positioning to Tekton.
  • Summit Clinical Research: Summit Clinical Research is a specialty site network focused on MASH/NASH and metabolic disease trials. Although Tekton's strategic partner, Summit operates its own competing site network targeting the same cardiometabolic sponsors.

Broad incumbents

  • Medpace: Medpace is a mid-size full-service CRO with a meaningful dedicated clinical trial site network across the U.S. and Europe. It competes for sponsor and CRO site-selection decisions, but operates a much broader service portfolio than Tekton's site-only model.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO with significant CNS and cardiometabolic focus. While listed as a Tekton partner, it also operates its own investigator site relationships and competes for the same sponsor study awards.
  • ICON plc: ICON plc is one of the largest global CROs with extensive site network capabilities through its acquired site alliances and embedded site services. Competes for large sponsor programs where Tekton is often a sub-site partner.
  • IQVIA: IQVIA is the world's largest CRO with a vast global site network and full-service capabilities. Represents the upper bound of the competitive landscape and the preferred-provider alternative for large pharma sponsors.
  • Labcorp Drug Development: Labcorp Drug Development (formerly Covance) is a top-tier global CRO offering both central laboratory services and clinical trial site network capabilities. Competes in the same sponsor contracts Tekton targets, particularly for integrated lab + site programs.
  • Parexel: Parexel is a global CRO with deep CNS and oncology expertise and an established Alliance Site network that includes Tekton. Competes with Tekton for sponsor site-selection decisions but also routes selected studies through Tekton via the Alliance program.
  • Syneos Health: Syneos Health is a global biopharmaceutical solutions provider with combined CRO and commercial capabilities, including site network services. Competes in sponsor preferred-provider decisions and has overlap with Tekton's therapeutic focus areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

TEKTON RESEARCH social profiles

Digital presence

TEKTON RESEARCH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TEKTON RESEARCH leadership team

Management profile

Number of profiles

Profiles5 records

TEKTON RESEARCH funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TEKTON RESEARCH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TEKTON RESEARCH

What does TEKTON RESEARCH do?

Tekton Research operates a network of 25+ physician-led clinical research sites across 9 U.S. states, conducting Phase 1–4 clinical trials for pharmaceutical sponsors, CROs, and biotech companies. The organization provides patient enrollment, site operations, data collection, regulatory compliance, and rater-calibrated assessments across therapeutic areas including neurology, psychiatry, cardiometabolic disease, infectious disease, general medicine, and pediatrics.

Is TEKTON RESEARCH a public or private company?

TEKTON RESEARCH is a private company. It is classified as private equity controlled and is currently operating.

When was TEKTON RESEARCH founded?

TEKTON RESEARCH was founded in 2006. It employs 101 to 250 people.

Where is TEKTON RESEARCH based?

TEKTON RESEARCH is headquartered in Austin, United States, in the North America region.

How does TEKTON RESEARCH make money?

One revenue line is on record: clinical Trial Services.

Who are TEKTON RESEARCH's main competitors?

Direct peers on record are Velocity Clinical Research, Flourish Research and Summit Clinical Research. Broad incumbents are Medpace, Worldwide Clinical Trials, ICON plc, IQVIA, Labcorp Drug Development, Parexel and Syneos Health.

Does TEKTON RESEARCH have an API?

No public API is recorded for TEKTON RESEARCH.

What industry is TEKTON RESEARCH in?

TEKTON RESEARCH's product category is Clinical Research Site Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireTekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to OhioTekton Research is expanding its partnership with Summit Clinical Research Solutions to bring metabolic dysfunction-associated steatohepatitis (MASH) clinical trials to New Carlisle, Ohio, under the supervision of Dr. Ashok Devatha. The New Carlisle site is embedded within Honey Creek Urgent Care, providing access to a high volume of patients with cardiometabolic risk factors while maintaining primary care continuity. The expansion follows the July 2025 launch of the partnership in Yukon, Oklahoma, where MASH trials are already underway.citybizTekton Research Adds Psychiatrist Dr. Amit Vijapura as CNS Key Opinion LeaderTekton Research, a multi-site clinical trial organization operating 25 research sites across North America, has appointed Dr. Amit Vijapura as a Central Nervous System Key Opinion Leader to strengthen its neuroscience and mental health clinical research capabilities. Dr. Vijapura is a board-certified psychiatrist and addiction medicine specialist with over 25 years of clinical research experience, having contributed to more than 40 Phase II and Phase III clinical trials across indications including major depressive disorder, schizophrenia, and Alzheimer's disease. The company stated the appointment aligns with its broader investment in neuroscience infrastructure, including specialized staffing and enhanced site capabilities to support complex psychiatric and neurological studies.GlobeNewswireTekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion LeaderTekton Research appointed Dr. Amit Vijapura as a CNS Key Opinion Leader, a board-certified psychiatrist with over 25 years of clinical research experience. He will support the organization's CNS portfolio, working with sponsors and investigators to strengthen study execution and site readiness. The appointment aims to expand CNS trial opportunities through his industry relationships.GlobeNewswireTekton Research Opens First Multi-Specialty Clinical Research Hub in San AntonioTekton Research announced the opening of its first multi-specialty clinical research hub in San Antonio, Texas, a physician-led facility focused on cardiometabolic and endocrine research. The hub features four dedicated exam rooms, a research monitor room, and access to a database of more than 12,000 participants, with leadership from Executive Medical Director Dr. Jara McDonald and Dr. Arti Thangudu. The company plans to host educational events this summer and is expanding with additional research hubs in Dallas, Austin, and Oklahoma City.GlobeNewswireTekton Research Appoints Dr. Jara McDonald as Executive Medical Director to Support Continued Growth in Cardiometabolic ResearchTekton Research appointed Dr. Jara McDonald as Executive Medical Director, leading medical strategy across its 25 North American sites. She will oversee participant safety, scientific integrity, and regulatory compliance, and currently serves as Principal Investigator at the San Antonio center. The appointment supports Tekton's expansion in cardiometabolic research.AdvarraClinical Conductor Clinical Trial Management System (CTMS)Clinical Conductor provides a Clinical Trial Management System (CTMS) designed to optimize operational and financial efficiency for research sites, as confirmed by various professionals in the field. Testimonials from professionals at organizations like Ascension Healthcare, Alcanza Clinical Research, and Tekton Research highlight the platform's significant contributions to managing patient journeys, finances, and overall clinical operations. Clinical Conductor continues to innovate by integrating features that enhance participant engagement and streamline workflows for clinical trials.GlobeNewswireTekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. MarketsTekton Research announced the addition of two new clinical trial research sites in New Carlisle, Ohio and Englewood, New Jersey, expanding its Neuroscience and General Medicine research capabilities. The Ohio site, embedded within New Carlisle Family Practice, will support trials in obesity, diabetes, hypertension, and cardiometabolic conditions, while the New Jersey site, embedded within The Brain Health Center, will focus on dementia, anxiety, depression, and other neuroscience studies. The expansion deepens access to diverse patient populations across the Midwest and Northeast U.S. markets.PR NewswireTekton Research Selects Todata's SiteGrades and Tod AI as Enterprise Business Intelligence SolutionTekton Research selected Todata Analytics' SiteGrades platform and Tod AI as its enterprise business intelligence solution. The partnership supports Tekton's expansion, which added seven new research sites in 2025. The implementation connects to existing systems with no migration or extra data entry.YahooTekton Research Selects Todata's SiteGrades and Tod AI as Enterprise Business Intelligence SolutionTekton Research selected Todata Analytics' SiteGrades platform and Tod AI as its enterprise business intelligence solution. The partnership supports Tekton's expansion, adding seven new research sites in 2025, and connects to existing systems with no migration. Tod AI operates within Todata's SOC 2- and HIPAA-compliant framework.GlobeNewswireCorey A. Collins Promoted to CEO of Tekton Research to Lead Next Era of GrowthCorey A. Collins was promoted to CEO of Tekton Research, a multi-site clinical trial company. He had served as President since January 2025, and the company expanded by seven research sites in 2025. Collins plans to continue growth in CNS and cardiometabolic trials.